Burkholderia pseudomallei: animal models of infection

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue SUPPL. 1, 2008, Pages

  Titball, Richard W ^a   Russell, Paul ^b   Cuccui, Jon ^c   Easton, Anna ^c   Haque, Ashraful ^c   Atkins, Tim ^b   Sarkar Tyson, Mitali ^b   Harley, Vicki ^c   Wren, Brendan ^c   Bancroft, Gregory J ^c  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Animal models; Burkholderia pseudomallei; Disease susceptibility; Melioidosis; Vaccine; Virulence

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BACTERIAL VACCINE; BURKHOLDERIA PSEUDOMALLEI VACCINE; CYTOKINE; GENTAMICIN; PROTEIN AROB; PROTEIN ILVL; PROTEIN SERC; UNCLASSIFIED DRUG;

ABSCESS; ACCURACY; ACUTE DISEASE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUXOTROPHY; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM MUTANT; BURKHOLDERIA PSEUDOMALLEI; CELLULAR IMMUNITY; CHRONIC DISEASE; COLONY FORMING UNIT; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG RESEARCH; GENE MUTATION; HAMSTER; HOST PATHOGEN INTERACTION; IMMUNOSURVEILLANCE; INFECTION RISK; INOCULATION; MELIOIDOSIS; MICROBIAL ACTIVITY; MOUSE STRAIN; NONHUMAN; PRIMATE; RISK ASSESSMENT; SINGLE DRUG DOSE; SITE DIRECTED MUTAGENESIS; SYMPTOM; VACCINE PRODUCTION; WILD TYPE;

ANIMALS; BACTERIAL VACCINES; BURKHOLDERIA PSEUDOMALLEI; CRICETINAE; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GOATS; HUMANS; MELIOIDOSIS; MICE; PRIMATES; RATS; RECURRENCE; SPECIES SPECIFICITY; VIRULENCE;

ANIMALIA; BURKHOLDERIA PSEUDOMALLEI; CRICETINAE; MUS; RATTUS;

EID: 58049159289     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(08)70026-9     Document Type: Article

References (46)

1. Dance D. Melioidosis - the tip of the iceberg. Clin Microbiol Rev 4 (1991) 52-60
2. Dance D. Melioidosis. Curr Opin Infect Dis 15 (2002) 127-132
3. Gan Y.H., Chua K.L., Chua H.H., Liu B.P., Hii C.S., Chong H.L., et al. Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system. Mol Microbiol 44 (2002) 1185-1197
4. Holden M.T.G., Titball R.W., Peacock S.J., Cerdeno-Tarraga A.M., Atkins T., Crossman L.C., et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA 101 (2004) 14240-14245
5. Howe C., Sampath A., and Spotnitz M. The pseudomallei Group: A review. J Infect Dis 124 (1971) 598-606
6. Dance D., Wuthiekanun V., Chaowagul W., and White N.J. The antimicrobial susceptibility of Pseudomonas pseudomallei - emergence of resistance in vitro and during treatment. J Antimicrob Chemother 24 (1989) 295-309
7. Samuel M., and Ti T.Y. Interventions for treating melioidosis. Cochrane Database Syst Rev (2001) CD001263.
8. Desmarchelier P.M., Dance D., Chaowagul W., Suputtamongkol Y., White N.J., and Pitt T.L. Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis. J Clin Microbiol 31 (1993) 1592-1596
9. Mays E.E., and Ricketts E.A. Melioidosis: recrudescence associated with bronchogenic carcinoma twenty six years following initial geographic exposure. Chest 68 (1975) 261-263
10. Robb R.J., Barnes J.L., and Ketheesan N. Reactivation of latent B. pseudomallei infection following immunosuppression. Tissue Antigens 66 (2005) 525
11. Cheng A.C., and Currie B.J. Melioidosis: epidemiology, pathophysiology and management. Clin Microbiol Revs 18 (2005) 383-416
12. Choy J.L., Mayo M., Janmaat A., and Currie B.J. Animal melioidosis in Australia. Acta Trop 74 (2000) 153-158
13. Currie B., Smith Vaughan H., Golledge C., Buller N., Sriprakash K.S., and Kemp D.J. Pseudomonas pseudomallei isolates collected over 25 years from a non-tropical endemic focus show clonality on the basis of ribotyping. Epidemiol Infect 113 (1994) 307-312
14. Dance D.A. Pseudomonas pseudomallei: danger in the paddy fields. Trans R Soc Trop Med Hyg 85 (1991) 1-3
15. Hicks C.L., Kinoshita R., and Ladds P.W. Pathology of melioidosis in captive marine mammals. Aust Vet J 78 (2000) 193-195
16. Narita M., Loganathan P., Hussein A., Jamaluddin A., and Joseph P. Pathological changes in goats experimentally inoculated with Pseudomonas pseudomallei. Natl Inst Anim Health Q (Tokyo) 22 (1982) 170-179
17. Sprague L.D., and Neubauer H. Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. J Vet Med B Infect Dis Vet Public Health 51 (2004) 305-320
18. Vedros N., Chow D., and Liong E. Experimental vaccine against Pseudomonas pseudomallei infections in captive cetaceans. Dis Aquatic Organ 5 (1988) 157-161
19. Yang S. Melioidosis research in China. Acta Trop 77 (2000) 157-165
20. Atkins T.P., Prior R.G., Mack K., Russell P., Nelson M., Prior J., et al. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J Med Microbiol 51 (2002) 539-547
21. Jones S.M., Ellis J.F., Russell P., Griffin K.F., and Oyston P.C. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol 51 (2002) 1055-1062
22. Leakey A., Ulett G., and Hirst R. BALB/c and C57BI/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb Pathog 24 (1998) 269-275
23. Ulett G., Norton R., and Hirst R. Combination antimicrobial therapy of acute Burkholderia pseudomallei infection in a mouse model. Pathology 31 (1999) 264-267
24. Chen Y.S., Hsiao Y.S., Lin H.H., Liu Y., and Chen Y.L. CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice. Infect Immun 74 (2006) 1699-1705
25. Chen Y.S., Hsiao Y.S., Lin H.H., Yen C.M., Chen S.C., and Chen Y.L. Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin. Vaccine 24 (2006) 750-758
26. Elvin S.J., Healey G.D., Westwood A., Knight S.C., Eyles J.E., and Williamson E.D. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. Infect Immun 74 (2006) 1706-1711
27. Healey G.D., Elvin S.J., Morton M., and Williamson E.D. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect Immun 73 (2005) 5945-5951
28. Jeddeloh J.A., Fritz D.L., Waag D.M., Hartings J.M., and Andrews G.P. Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 71 (2003) 584-587
29. Smith M., Angus B., Wuthiekanun V., and White N. Arabinose assimulation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect Immun 65 (1997) 4319-4321
30. Ulett G.C., Labrooy J.T., Currie B.J., Barnes J.L., and Ketheesan N. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection. Microbes Infect 7 (2005) 1263-1275
31. Atkins T., Prior R.G., Mack K., Russell P., Nelson M., Oyston P.C., et al. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect Immun 70 (2002) 5290-5294
32. Cuccui J., Easton A., Bancroft G., Oyston P.C.F., Titball R.W., and Wren B.W. Development of signature tagged mutagenesis in Burkholderia pseudomallei to identify mutants important in survival, attenuation and pathogenesis. Infect Immun 75 (2007) 1186-1195
33. Brett P., Mah D., and Woods D. Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun 62 (1994) 1914-1919
34. Bryan L.E., Wong S.E., Woods D., Dance D., and Chaowagul W. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Di 5 (1994) 170-178
35. Woods D.E., Jones A.L., and Hill P.J. Interaction of insulin with Pseudomonas pseudomallei. Infect Immun 61 (1993) 4045-4050
36. Deshazer D., Brett P., Carlyon R., and Woods D. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol 179 (1997) 2116-2125
37. Jones A., Deshazer D., and Woods D. Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei. Infect Immun 65 (1998) 4972-4977
38. Brett P.J., and Woods D.E. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun 64 (1996) 2824-2828
39. Haque A., Chu K., Easton A., Stevens M.P., Galyov E.E., Atkins T., et al. A live experimental vaccine against Burkholderia pseudomallei elicits CD4(+) T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. J Infect Dis 194 (2006) 1241-1248
40. Liu B.P., Koo G.C., Yap E.H., Chua K.L., and Gan Y.H. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun 70 (2002) 504-511
41. Trakulsomboon S., Pitt T.L., and Dance D.A. Molecular typing of Pseudomonas pseudomallei from imported primates in Britain. Vet Rec 135 (1994) 65-66
42. Kaufmann A.F., Alexander A.D., Allen M.A., Cronin R.J., Dillingham L.A., Douglas J.D., et al. Melioidosis in imported non-human primates. J Wildl Dis 6 (1970) 211-219
43. Reckseidler-Zenteno S.L., DeVinney R., and Woods D.E. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun 73 (2005) 1106-1115
44. Reckseidler S., Deshazer D., Sokol P., and Woods D. Detection of bacterial virulence genes by subtractive hybridisation: Identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 69 (2001) 34-44
45. Chua K.L., Chan Y.Y., and Gan Y.H. Flagella are virulence determinants of Burkholderia pseudomallei. Infect Immun 71 (2003) 1622-1629
46. Tuanyok A., Tom M., Dunbar J., and Woods D.E. Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis. Infect Immun 74 (2006) 5465-5476